Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Alprazolam Treatment Report
What is Alprazolam?

Alprazolam is a benzodiazepine used for the treatment of anxiety disorder, panic disorder, with or without agoraphobia, and anxiety associated with depression. Off label it is used to treat anxiety in children.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Anxiety 16 3
Other 3 1
General health 1 0
Stress 1 0
Panic Disorder 1 0
Depression 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 33%
Mild
0 0%
None
2 67%

Most commonly reported side effects

Sedation
1 33%
Sleepiness
1 33%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Alprazolam. See all 14 dosages

  0.05mg as needed 0.25mg as needed 0.5mg as needed 0mg as needed 1mg as needed 2 0.5mg as needed 0.25 mg weekly 0.25 mg daily 0.5 mg daily 0.75 mg daily 1 mg daily 2 mg daily 3 mg daily 6 mg daily
  1 Number of Patients: 1 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3  

Currently Taking Alprazolam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
0
3
5

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 67%
Usually
1 33%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 33%
Not at all
2 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.